Key Highlights

● Revenue rose sharply on AI infrastructure demand

● Gross Margin slipped below guidance

● Full-year Revenue range rose while Earnings range fell

● Axcelis Merger still needs approval in China

Veeco Instruments Inc. (NASDAQ:VECO), a semiconductor process equipment maker that features among US-listed technology stocks with a direct line to chip factory spending, posted third-quarter results in which revenue stood well above the prior-year period. Net Income also rose from a year earlier on a GAAP basis, although gross margin narrowed and non-GAAP Diluted Earnings per Share were flat with the prior-year quarter.

The release, furnished to the Securities and Exchange Commission alongside a slide presentation for the evening conference call, set out a fourth-quarter revenue range above the level just reported. It also revised the full-year outlook in a way that pulled in opposite directions: the revenue range moved up from the range, while the GAAP and non-GAAP earnings per share ranges both moved down.

That split is the central feature of the update. Sales momentum, tied by management to AI infrastructure investment, is visible in the Top Line and in contract liabilities on the balance sheet. Profit conversion is lagging, with cost of sales and operating expenses both growing from the prior-year period. Meanwhile, the company remains a party to a pending merger with Axcelis (NASDAQ:ACLS) Technologies, and approval in China is still listed among the risks to completing that transaction.

Inside the Income Statement at Veeco Instruments

Revenue rose by roughly a quarter from the third quarter of last year and also increased from the second quarter of this year. According to the slide presentation, the figure landed inside the range management had provided in August, so the sales result was consistent with what the company had told investors to expect rather than a departure from it.

Gross margin was the weaker line. GAAP gross margin fell from the prior-year quarter, and non-GAAP gross margin fell by a similar degree. The presentation shows that non-GAAP gross margin came in below the range management had guided for the quarter. Non-GAAP operating expenses, by contrast, finished slightly under the guided range, which offset a portion of the margin shortfall.

Research and development spending climbed from the prior-year quarter, and selling, general and administrative expense also increased. Even with those higher costs, GAAP Operating Income improved from a year earlier, as did non-GAAP operating income. GAAP net income and GAAP diluted earnings per share advanced as well. Non-GAAP net income rose too, but a higher diluted share count appears to have absorbed that gain at the per-share level, since non-GAAP diluted earnings per share matched the prior-year figure.

Year-to-date figures tell a somewhat different story from the quarter alone. Revenue for the year to date exceeded the same stretch of last year, but GAAP net income and GAAP diluted earnings per share over that period fell short of the prior-year totals. The company's Quarterly Report also shows that gross margin for the year-to-date period sat below the comparable period of last year, so the third-quarter narrowing fits a pattern that has been present for much of the year.

Merger costs were a modest line item, slightly below the prior-year quarter. The presentation guides to a larger total for the full year as the transaction remains open.

Where the Revenue Came From at Veeco Instruments

The earnings release itself does not break revenue down by market, but the accompanying slide presentation does, and the mix shifted noticeably from the second quarter. Semiconductor remained the largest category, accounting for the clear majority of the total and rising modestly in dollar terms from the prior quarter.

The biggest change came in compound semiconductor, where revenue nearly doubled from the second quarter and its share of the total roughly doubled as well. Data storage declined slightly from the prior quarter, while the scientific and other category also fell. Those moves meant that nearly all of the sequential growth was attributable to compound semiconductor and, to a lesser extent, the core semiconductor category.

Geography moved as well. Asia-Pacific excluding China became a far larger contributor, rising sharply from the second quarter and accounting for the largest regional share. The United States also rose, as did the combined bucket of Europe, the Middle East, Africa and the rest of the world. China went the other way, with revenue dropping sharply from the second quarter and its share of the total shrinking meaningfully. Market data of the second-quarter call showed China at about a quarter of revenue in that earlier period, which puts the third-quarter drop in context.

The shift matters for how the top line is read. Growth in the quarter did not rely on China, and regional Diversification improved compared with the prior quarter.

AI Infrastructure as the Demand Thread

Chief Executive Bill Miller framed the quarter as evidence of "solid execution and significant opportunities" across the business. He linked the opportunity set to AI infrastructure investment, which he said is accelerating technology transitions in leading-edge logic and memory, advanced packaging and high-speed optical connectivity. He also expressed the belief that the company is positioned to pass a notable revenue milestone for full-year results next year, a statement repeated in the slide presentation as a clear path toward that level.

The presentation highlighted significant order wins in front-end semiconductor, advanced packaging and silicon photonics, along with progress toward commercial adoption of the company's ion beam deposition tool. It did not provide Backlog or bookings totals, so the size of those wins cannot be measured from the document. The Balance Sheet offers one related signal: contract liabilities stood at the end of September well above the level reported at the end of last year.

Management also supplied market estimates. The presentation projects growth in the served addressable market for the company's semiconductor products through the end of the decade, with the largest gains expected in front-end and annealing. For compound semiconductors, management projects a substantial expansion over a similar period, driven by silicon photonics, other photonics and gallium nitride power. It cited indium phosphide lasers for AI infrastructure as a specific opportunity over the coming years. These are the company's own projections and have not been independently verified.

Orders Set Up Before the Quarter Began

The third-quarter commentary follows a second-quarter call in which management described large advanced-packaging orders for wet-processing and lithography systems. According to market data of that call, most of those orders were scheduled for delivery next year and were not expected to influence this year's gross margins. Data-storage bookings were also said to extend into next year.

The same account described the company's Laser Spike Annealing and Nanosecond Annealing products as having set record quarterly revenue in the second quarter. Laser Spike Annealing was described as the production tool of record at the leading-tier logic customers. Management also said a leading-tier customer had placed a follow-on order for an additional Nanosecond Annealing system, while another logic customer had received an evaluation tool.

In compound semiconductors, a global optical and photonics company had selected the Lumina+ MOCVD system to make indium phosphide lasers for datacom. Management expected the Lumina MOCVD and Spector ion-beam deposition systems to support growth in silicon photonics.

the Business news site Pulse, reporting on the second-quarter results in August, quoted Miller as saying that "The rapid expansion of AI is driving increased demand across" the portfolio, and cited what he described as growing visibility into next year. The third-quarter statements continue that same theme.

The Capacity Build and Its Cost

Spending to meet that demand is one plausible pressure on profitability, and management had already flagged it. On the second-quarter call, according to market data, Kiernan, speaking for the finance side of the business, said the company planned to more than double capacity in advanced packaging and silicon photonics during next year through internal production expansion, outsourcing partners in Southeast Asia, hiring and supply-chain expansion. Those efforts were expected to add to operating expenses in the second half of this year and to reduce full-year gross margin.

The third-quarter presentation states that management is "executing Manufacturing expansion plan" and making "deliberate investments to support higher demand." It provides no capacity figures or Capital Expenditure plan, and capital expenditures were small in both the second and third quarters. Inventories rose from the prior quarter, which is consistent with preparing for higher shipments, though the presentation does not make that connection explicitly.

What can be stated is that the margin came in under guidance, that capacity spending had been identified in advance as a headwind, and that the full-year earnings range has since been lowered.

According to the second-quarter account, shipments from growth programs were expected to ramp modestly late in the fourth quarter, with a larger ramp beginning in the first quarter of next year and gathering momentum in the following quarter. That timeline would place much of the revenue benefit beyond the current fiscal year, while some of the costs arrive earlier.

What the Revised Outlook Actually Says

For the fourth quarter, the company guided to a revenue range sitting above the third-quarter result at both ends. The GAAP and non-GAAP diluted earnings per share ranges are also above the third-quarter outcomes, which implies an expected improvement in profitability on higher volume.

The full-year comparison is where the mixed message emerges. Pulse's August report set out the previous full-year guidance, and setting it beside the new figures shows that the low and high ends of the revenue range each moved up modestly. Over the same interval, the low and high ends of GAAP diluted earnings per share moved down, and the non-GAAP range also moved down, with the upper end declining by more than the lower end. In practice, the company now anticipates somewhat more sales this year but somewhat less profit per share than it did in August.

Those ranges are subject to the forward-looking statement cautions contained in the release, which name the merger, trade and regulatory factors, the company's transformation initiative and other risks.

The Balance Sheet Going Into Year-End

Cash, cash equivalents and short-term investments rose from the prior quarter, helped by Operating Cash Flow that far exceeded the quarter's capital spending. Long-term Debt remained on the balance sheet, and total stockholders' Equity was reported at the end of September alongside inventories that continued to build.

The growth in contract liabilities stands out in this picture. A contract Liability generally records amounts received or billed ahead of revenue recognition, and the increase from the end of last year may reflect the larger orders management has been describing. The release does not comment on the source of the change, so that link remains an inference rather than a stated fact.

The Axcelis Merger Remains Unfinished Business

Veeco signed a merger agreement with Axcelis Technologies and Victory Merger Sub in September of last year. Under the agreement, as described in the company's quarterly report, the merger Subsidiary will merge into Veeco, which will then become a Wholly Owned Subsidiary of Axcelis, subject to closing conditions being satisfied or waived. The quarterly report lists the transaction as still pending at the end of September.

Stockholders have already had their say. Axcelis announced in February that its holders had voted to approve all proposals related to the merger, and that release described the State Administration for Market Regulation of China as the final pending regulatory approval. At that point, the companies expected completion in the second half of this year. On the second-quarter call,, Miller said shareholders of both companies had approved the deal and that all regulatory clearances had been obtained except China antitrust approval, and the company continued to target a closing in the second half.

The third-quarter release and presentation still list regulatory approval in China as a risk. The quarterly report's risk factors also point to possible termination, appraisal rights under Delaware law and fluctuation in the Axcelis share price.

The Wider Chip Backdrop

The company's report arrives during a period of extraordinary industry sales. The Semiconductor Industry Association said in August that global semiconductor sales in the second quarter rose sharply from the first quarter, with June sales far above the same month of last year. Sales growth was led by the Americas, with Asia-Pacific and China also posting strong annual gains. The association's chief executive, John Neuffer, said the results underscored "the strength of global chip demand" and that annual sales this year were on course to set a very high level.

For an equipment supplier, chip sales are an indirect signal because tool purchases depend on factory Investment decisions. Even so, the demand themes Veeco emphasized, including AI infrastructure, advanced packaging and photonics, sit within the same broad cycle the association described. Trade conditions remain a Factor as well, since the quarterly report names export controls, the trade dispute between the United States and China and the inability to obtain export licenses among the risks to the business.

Points the Record Leaves Open

Several questions remain beyond the scope of the published documents. These include the specific reason for the gross margin shortfall, the source of the decline in China revenue, the size of the order wins highlighted in the presentation and the timing of any decision from Chinese regulators.

Observers following the company in coming weeks are likely to focus on whether fourth-quarter shipments align with the revised range, whether non-GAAP gross margin recovers from the third-quarter level and whether the merger review concludes within the stated timeframe. Each of those outcomes would come through company filings, which remain the primary record.